Poor
Not Aligned
Patient Risk:
Moderate
Summary
The response contains numerous claims marked absent from the provided FDA label excerpts, including meal/food timing effects on absorption/peak and side-effect timing, alcohol-specific interaction details, and urgent-care triggers. Only dizziness/somnolence and the general CNS-depressant/respiratory depression interaction are supported by the supplied label sections.
Category Scores
Accurate Statements
The main safety risks increase when combined with other substances that depress the central nervous system.
Supported by 5.4 Respiratory Depression (monitor for respiratory depression/sedation when co-prescribing with CNS depressants, particularly opioids, or in underlying respiratory impairment).
Common side effects to monitor include dizziness.
Partially supported by 5.5 Dizziness and Somnolence (dizziness experienced in trials).
Common side effects to monitor include drowsiness.
Partially supported by 5.5 Dizziness and Somnolence (somnolence experienced in trials).
Seek urgent care if pregabalin side effects include trouble breathing.
Partially supported by 5.4 Respiratory Depression (respiratory depression is a serious labeled concern; however, 'urgent care' threshold is not explicitly stated in the provided excerpt).
Unsupported Statements
Lyrica (pregabalin) can be taken with or without food.
Label excerpt provided does not include meal/food administration instructions; evaluation indicates absent from the label.
Food slows pregabalin absorption.
Evaluation indicates absent from the label (no supporting excerpt).
Food can delay peak pregabalin levels in the body.
Evaluation indicates absent from the label (no supporting excerpt).
Delaying peak levels can change when side effects show up (e.g., dizziness or drowsiness).
Evaluation indicates absent from the label; hypothesized mechanism not supported.
Food may delay the onset of side effects rather than permanently changing the safety profile.
Evaluation indicates absent from the label.
Food can delay pregabalin’s peak effect.
Evaluation indicates absent from the label.
Delaying peak effect may help some people avoid sudden onset of side effects right after a dose (such as sleepiness or lightheadedness).
Evaluation indicates absent from the label; implies benefit not supported.
For many patients, food mainly affects the timing of side effects rather than preventing them entirely.
Evaluation indicates absent from the label.
The main safety concerns for pregabalin are dose- and blood-level-related.
Evaluation indicates absent from the label; framed as 'main' but not supported by provided excerpt.
Anything that shifts absorption timing (including taking with or without food) can affect when side effects occur.
Evaluation indicates absent from the label.
Taking pregabalin differently relative to meals (with food vs without) may cause significantly more sedation or unsteadiness in some people.
Evaluation indicates absent from the label.
Staying consistent with how pregabalin is taken (always with food or always without) can reduce variability in side effects.
Evaluation indicates absent from the label.
Alcohol is an example of a central nervous system depressant interaction with pregabalin.
Evaluation indicates absent from the label (no supporting excerpt about alcohol).
Alcohol can amplify dizziness, drowsiness, and impaired coordination in patients taking pregabalin.
Evaluation indicates absent from the label.
Alcohol use with pregabalin can raise fall or accident risk.
Evaluation indicates absent from the label.
Food mainly affects absorption timing.
Evaluation indicates absent from the label.
People who experience side effects should aim for consistency with meals when taking pregabalin.
Evaluation indicates absent from the label.
People taking pregabalin should avoid alcohol due to additive sedation risk.
Evaluation indicates absent from the label.
Seek urgent care if pregabalin side effects include severe confusion.
Evaluation indicates absent from the label.
Seek urgent care if pregabalin side effects include fainting.
Evaluation indicates absent from the label.
Seek urgent care if pregabalin side effects include severe unsteadiness.
Evaluation indicates absent from the label.
Serious symptoms are especially concerning if alcohol or other sedating medicines were involved.
Evaluation indicates absent from the label.
If pregabalin is taken at different times relative to meals, side effects may appear at different times after dosing.
Evaluation indicates absent from the label.
Food can delay pregabalin peak levels when dosing timing varies relative to meals.
Evaluation indicates absent from the label.
Contradictions
Important Omissions
The response does not anchor claims about administration/food with any provided label-supported dosing instruction, and it introduces many meal-timing assertions without label support. Missing is the FDA-labeled statement (if any) regarding administration with/without food.
Importance:
High
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported claims about meal timing effects on absorption/peak and side-effect timing, plus unsupported alcohol-specific interaction details and urgent-care thresholds, could mislead patients about when/what to monitor or how to mitigate labeled risks.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Major portion of content (especially food/meal timing and alcohol/urgent-care guidance) is not supported by the provided FDA label excerpts.
Suggested Improvement
Remove or rewrite meal/food timing mechanistic claims and alcohol-specific interaction details unless supported by the FDA label sections; align safety monitoring language to labeled content (e.g., dizziness/somnolence and CNS-depressant/respiratory depression monitoring) without adding unsupported urgent-care triggers or mechanistic benefit claims.